Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Retinitis pigmentosa is a degenerative disease affecting the photoreceptor cells in the retina, known as cones and rods.

30 May 2022

Ocular toxoplasmosis found to be common among Australians

One in 150 Australians have retinal scars caused by the Toxoplasma parasite, according to new Flinders University analysis.

16 May 2022

The promise of RNA medicine is targeted and personalized

The development of messenger RNA (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has only increased the impetus in this field.

11 May 2022

Poor vision in older adults often mistakenly conflated with mild cognitive impairment

Millions of older people with poor vision are at risk of being misdiagnosed with mild cognitive impairments, according to a new study by the University of South Australia.

10 May 2022

Single-cell-resolution map of retinal pigment epithelium could help develop precise therapies for degenerative diseases

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception.

6 May 2022

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

In a recent randomized clinical trial of hospitalized patients with COVID-19 and cardio-metabolic risk factors, the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin did not significantly reduce patients' risk of organ failure, kidney problems, or death compared with placebo, although numerically fewer participants treated with dapagliflozin experienced these outcomes. The findings are published in CJASN.

29 Apr 2022

Treatment for retinal vein occlusion yields long-lasting vision gains, study shows

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years.

21 Apr 2022

Alcohol consumption may be a modifiable risk factor for age-related macular degeneration

Even though Dry January is over, new research suggests you may want to consider keeping the no-alcohol challenge going all year, especially if you're among the nearly 2 million Americans who have age-related macular degeneration (AMD), a sight-threatening eye condition.

28 Feb 2022

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested to advance ocular drug discovery and development.

29 Jan 2022

Researchers uncover new findings about the role of tau in neurodegenerative disease

Utilizing cutting-edge proteomics, researchers at the Buck Institute and elsewhere have mapped the "tau interactome" uncovering new findings about the role of tau in neurodegenerative disease. Publishing in Cell, scientists found that mutant tau impacts the function of mitochondria in human neurons.

20 Jan 2022

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

In a preliminary study of 106 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers report that as many as a third of those with the blinding retinal disease may someday be able to safely stop eye injection therapy without further vision loss.

18 Jan 2022

Health burden from fish smoking possibly impacts millions of workers in coastal Africa

Millions of workers in coastal Africa—most of them women—spend their days preserving fish by smoking them in rudimentary, wood-fired mud ovens.

12 Jan 2022

Scientists find that having one kind of autoimmune disease can lead to another

Researchers at the University of Colorado Anschutz Medical Campus have discovered that having one kind of autoimmune disease can lead to another.

4 Jan 2022

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

15 Dec 2021

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Steven DeVries, MD, PhD, the David Shoch, MD, PhD, professor of Ophthalmology, has received an International Research Collaborators Award from Research to Prevent Blindness.

14 Dec 2021

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease.

9 Dec 2021

UVA researchers uncover common link between lupus and macular degeneration

University of Virginia School of Medicine researchers have made a discovery linking lupus, a potentially debilitating autoimmune disorder, and macular degeneration, a leading cause of blindness.

9 Dec 2021

Infantile cataracts are more common and problematic than thought

Three days after Canyon Brown was born, the attending pediatrician discovered a problem.

8 Dec 2021

Cataract surgery associated with lower risk of dementia

Cataracts affect most older adults at risk for dementia, and now researchers are finding strong evidence that cataract surgery is associated with a lower risk of developing dementia.

6 Dec 2021

HyVIS project to develop bionic synapses for retinal prostheses

HyVIS, the European project coordinated by the IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology), is about to start.

3 Dec 2021

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Ocular toxoplasmosis found to be common among Australians

The promise of RNA medicine is targeted and personalized

Poor vision in older adults often mistakenly conflated with mild cognitive impairment

Single-cell-resolution map of retinal pigment epithelium could help develop precise therapies for degenerative diseases

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Treatment for retinal vein occlusion yields long-lasting vision gains, study shows

Alcohol consumption may be a modifiable risk factor for age-related macular degeneration

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Researchers uncover new findings about the role of tau in neurodegenerative disease

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

Health burden from fish smoking possibly impacts millions of workers in coastal Africa

Scientists find that having one kind of autoimmune disease can lead to another

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

UVA researchers uncover common link between lupus and macular degeneration

Infantile cataracts are more common and problematic than thought

Cataract surgery associated with lower risk of dementia

HyVIS project to develop bionic synapses for retinal prostheses

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Newsletters you may be interested in